Rav Hemo Kaplan Lupus Coagulant

Front 1

lupus anticoagulant occurs in

Back 1

lupus anticoagulant occurs in 5-10 % of patients with SLE
that

Front 2

this is what trype of mmunoglobulin

Back 2

this is IgM or IgG immunoglobulin

Front 3

what does it do with PTT

Back 3

prolong the PTT by binding phospholipids used in assay

Front 4

this is laboratory artifact and does not promote bleeding

Back 4

this is laboratory artifact and does not promote bleeding

Front 5

will be it correct if mixed with normal plasma in a 1:1 dilution

Back 5

PTT will not correct if mixed with normal plasma in a 1:1 dilution

Front 6

Rusell venom test will be or not prolonged in the disease
with the lupus anticoagulant

Back 6

Rusell venom test will be prolonged in the disease

d dimer will be normal or high. d dimer are typically elevated in the presence of clot

circulating anticoagulants should be suspected when coagulopathy developed in previously healthy person
a patient with known coagulopathy becomes resistant to a replacement therapy
lab test produces conflicts resul

Front 7

with the lupus anticoagulant
PT
vWf
BT
platelet count
d dimer

Back 7

with the lupus anticoagulant
1. PT will be normal or slightly prolonged
2 vWf BT platelet count will be normald dimer will be normal or high. d dimer are typically elevated in the presence of clot

Front 8

when circulating anticoagulants should be suspected

Back 8

circulating anticoagulants should be suspected when coagulopathy developed in previously healthy person
a patient with known coagulopathy becomes resistant to a replacement therapy
lab test produces conflicts results